Reinventing Your Supply Chain

News

Press Release:
September 2018

Aphena to Exhibit at 17th Annual Contract Pharma Conference

EASTON, Maryland — The Aphena Pharma Solutions sales team will be exhibiting at the 17th Annual Contract Pharma Contracting and Outsourcing Conference, slated for Sept. 27-28, 2018, at the Hyatt Regency in New Brunswick, New Jersey. They will be meeting with customers and prospective new clients to learn about their business models and their packaging and manufacturing needs, as well as to discuss strategies for development and implementation for serialization.

Set in the heart of New Jersey's pharmaceutical industry, the event provides an ideal venue for easy, informal discussions about manufacturing, packaging, laboratory services and more. The conference and one-day tabletop exhibition will be held on Thursday, Sept. 27, with an additional half day of conference sessions held on Friday, Sept. 28.

The keynote speaker for the conference will be Ben Locwin, head of clinical quality at Karyopharm Therapeutics, who will present "Trends Driving Innovation & Successful Collaboration." A member of several pharma and biotech boards of directors and advisory boards. He has been featured in The Wall Street Journal, Forbes magazine, USA Today and other top-tier media outlets.

Other conference topics include:

  • Mutual Recognition of Inspections
  • Pharma Manufacturing Compliance Trends
  • FDA Investigator Updates & Insights
  • Pfizer's External Drug Product Planning & Management
  • CMO Market Trends Analysis
  • Data Integrity Outsourcing Trends
  • Quality Metrics Guidance
  • Drug Development Partnerships with CDMOs
  • The Future of Pharmaceutical R&D Outsourcing

For more information about the conference or to register, visit conference.contractpharma.com.

Aphena Pharma Solutions Inc. is an industry-leading organization providing turnkey contract packaging and manufacturing solutions for the pharmaceutical, OTC, dietary supplement, animal health, consumer health and medical device markets. With two separate FDA- and DEA-registered, GDUFA-compliant and serialization-ready sites in the U.S., Aphena handles solid dose, liquids, gels, creams, ointments, foams, suspensions and lotions. For more information about Aphena, visit aphenapharma.com.

   
 
Corporate Office: 1-866-465-4506